相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells
Dinisha Kamble et al.
CELLS (2021)
SIRT2 and SIRT3 expression correlates with redox imbalance and advanced clinical stage in patients with multiple myeloma
Alessandro Allegra et al.
CLINICAL BIOCHEMISTRY (2021)
Mechanisms of cancer stem cell senescence: Current understanding and future perspectives
Da-Yong Zhang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2021)
A review of the racial heterogeneity of breast cancer stem cells
Eric Gyan et al.
GENE (2021)
Cancer stem cells targets and combined therapies to prevent cancer recurrence
Pawan Kumar Raghav et al.
LIFE SCIENCES (2021)
Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells via the FoxO3a-Bmi-1 Axis
Do-Hee Kim et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
The prognostic value of NRF2 in breast cancer patients: a systematic review with meta-analysis
Micaela Almeida et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Inhibition of aldehyde dehydrogenase-1 and p-glycoprotein-mediated multidrug resistance by curcumin and vitamin D3 increases sensitivity to paclitaxel in breast cancer
Yasmeen M. Attia et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Luteolin induces mitochondrial apoptosis in HT29 cells by inhibiting the Nrf2/ARE signaling pathway
Huan Yang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
The Function and Prognostic Significance of Cripto-1 in Colorectal Cancer
Jun Sato et al.
CANCER INVESTIGATION (2020)
Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer
Mamta Kumari et al.
CURRENT CANCER DRUG TARGETS (2020)
Expression of Nrf2 and NF-κB transcription factors in breast cancer and breast fibroadenoma: Insights for a new therapeutic approach
Camila Maria Simplicio-Revoredo et al.
Oncotarget (2020)
Expression of Cripto-1 predicts poor prognosis in stage I non-small cell lung cancer
Chunhua Xu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance
Zahra Payandeh et al.
BIOCHIMIE (2020)
Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells
Hye-Kyung Park et al.
CANCER RESEARCH (2019)
Luteolin, a flavonoid, as an anticancer agent: A review
Muhammad Imran et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects
Anoop K. Yadav et al.
STEM CELL REVIEWS AND REPORTS (2019)
Brusatol, an NRF2 inhibitor for future cancer therapeutic
Sabrina J. Cai et al.
CELL AND BIOSCIENCE (2019)
Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses
Li Li et al.
PHYTOMEDICINE (2019)
The Role of Nrf2 signaling in cancer stem cells: From stemness and self-renewal to tumorigenesis and chemoresistance
Houman Kahroba et al.
LIFE SCIENCES (2019)
The expression of the embryonic gene Cripto-1 is regulated by OCT4 in human embryonal carcinoma NCCIT cells
Sung-Won Park et al.
FEBS LETTERS (2018)
Cancer stem cell in breast cancer therapeutic resistance
Xupeng Bai et al.
CANCER TREATMENT REVIEWS (2018)
Selective Cytotoxicity of Luteolin and Kaempferol on Cancerous Hepatocytes Obtained from Rat Model of Hepatocellular Carcinoma: Involvement of ROS-Mediated Mitochondrial Targeting
Enayatollah Seydi et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2018)
High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling
Donghyeok Kim et al.
CELL DEATH & DISEASE (2018)
Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
Kristina Witt et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma
Qiang Liu et al.
MOLECULAR CANCER (2017)
Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells
Hong-Quan Duong et al.
ANTIOXIDANTS (2017)
Luteolin induces apoptosis by ROS/ER stress and mitochondrial dysfunction in gliomablastoma
Qiang Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer
Maria Cristina Rangel et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Luteolin induces cholangiocarcinoma cell apoptosis through the mitochondrial-dependent pathway mediated by reactive oxygen species
Natthawan Kittiratphatthana et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance
A. L. Furfaro et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells
Ilaria Dando et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Cripto-1 as a novel therapeutic target for triple negative breast cancer
Nadia P. Castro et al.
ONCOTARGET (2015)
Regulation of MnSOD Enzymatic Activity by Sirt3 Connects the Mitochondrial Acetylome Signaling Networks to Aging and Carcinogenesis
Randa Tao et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo
Song Chian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
NRF2 immunolocalization in human breast cancer patients as a prognostic factor
Yoshiaki Onodera et al.
ENDOCRINE-RELATED CANCER (2014)
The significance of a Cripto-1-positive subpopulation of human melanoma cells exhibiting stem cell-like characteristics
Luigi Strizzi et al.
CELL CYCLE (2013)
Role of Cripto-1 during Epithelial-to-Mesenchymal Transition in Development and Cancer
Maria C. Rangel et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Cancer Stem Cells and Novel Targets for Antitumor Strategies
Gerald J. Prud’homme
CURRENT PHARMACEUTICAL DESIGN (2012)
Cancer stem cells and metastasis
Katia Sampieri et al.
SEMINARS IN CANCER BIOLOGY (2012)
Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
Xiuwen Tang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Role of Cripto-1 in Stem Cell Maintenance and Malignant Progression
Caterina Bianco et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
In vitro and in vivo hepatoprotective effects of the aqueous extract from Taraxacum officinale (dandelion) root against alcohol-induced oxidative stress
Yanghee You et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
Reactive oxygen species in cancer
Geou-Yarh Liou et al.
FREE RADICAL RESEARCH (2010)
Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Yong Lin et al.
CURRENT CANCER DRUG TARGETS (2008)
Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer
X-Y Zhong et al.
HISTOPATHOLOGY (2008)
分享论文
